Dr. Makhoul is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 216-444-2200Fax+1 216-445-6290
Summary
- Ahed Makhoul, MD, MBA, is an internal medicine specialist based in Cleveland, OH, with a subspecialty in Hospice & Palliative Medicine. Currently practicing at The Cleveland Clinic Main Campus. He completed both his residency in internal medicine and fellowship in hospice and palliative medicine at the Cleveland Clinic Foundation. Dr. Makhoul graduated from the Faculty of Medicine of Albaath University in 2013, and from Weatherhead School of Management (CWRU) in 2024. His published works include research on topics such as response rates to methylnaltrexone in cancer patients, the role of palliative care in COVID-19, a personalized prediction model for acute myeloid leukemia patients using AI, and the impact of BCOR and BCORL1 mutations in myelodysplastic syndromes.
Education & Training
- Cleveland Clinic FoundationFellowship, Hospice and Palliative Medicine, 2019 - 2020
- Cleveland Clinic FoundationResidency, Internal Medicine, 2016 - 2019
- Faculty of Medicine of Albaath UniversityClass of 2013
Certifications & Licensure
- OH State Medical License 2018 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hospice and Palliative Medicine
Publications & Presentations
PubMed
- 1 citationsResponse Rates to Methylnaltrexone in Hospitalized Cancer Patients.David Harris, David Kalir, Cory Chevalier, Krista Dobbie, Flannery Fielding
The American Journal of Hospice & Palliative Care. 2023-10-01 - 12 citationsThe role of palliative care in COVID-19.Denise Sese, Ahed Makhoul, Laura Hoeksema, Laura Shoemaker
Cleveland Clinic Journal of Medicine. 2020-05-29 - 17 citationsBCOR and BCORL1 mutations in myelodysplastic syndromes (MDS): clonal architecture and impact on outcomes.Nour Abuhadra, Sudipto Mukherjee, Karam Al-Issa, Vera Adema, Cassandra M. Hirsch
Leukemia & Lymphoma. 2019-01-08
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: